Spondylodiscitis due to Peptostreptococcus spp: a case report.
Fraisse
Thibaut
T
Lavigne
Jean Philippe
JP
Lechiche
Catherine
C
Leroux
Jean Louis
JL
Sotto
Albert
A
D000284:Administration, Oral; D000368:Aged; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001416:Back Pain / Q000382:microbiology / Q000473:pathology*; D019818:Clavulanic Acid / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D015299:Discitis / Q000382:microbiology / Q000473:pathology*; D004359:Drug Therapy, Combination; D016908:Gram-Positive Bacterial Infections / Q000150:complications / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007103:Immobilization; D007275:Injections, Intravenous; D008159:Lumbar Vertebrae / Q000473:pathology*; D008297:Male; D010462:Peptostreptococcus / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D019818:Clavulanic Acid; D002981:Clindamycin; D000658:Amoxicillin